Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy
Michael I. D’Angelica(Memorial Sloan Kettering Cancer Center), Clifford Y. Ko(University of California, Los Angeles), Matthew Dixon(Rush University Medical Center), Rebecca A. Snyder(The University of Texas MD Anderson Cancer Center), Carlos Fernández‐del Castillo(Massachusetts General Hospital), Bradley N. Reames(Nebraska Medical Center), John C. McAuliffe(Albert Einstein College of Medicine), Shishir K. Maithel(Broad Institute), Sepideh Gholami(University of California, Davis), Pablo E. Serrano(Impact), Umut Sarpel(Mount Sinai Medical Center), Marina Talamonti(NorthShore University HealthSystem), Dominic E. Sanford(The University of Queensland), Mithat Gönen(Memorial Sloan Kettering Cancer Center), Mark E. Cohen(American College of Surgeons), Emily C. Zabor(Cleveland Clinic), Courtney L. Scaife(Huntsman Cancer Institute), Mark J. Ott(Intermountain Healthcare), Carlos H.F. Chan(University of Iowa Hospitals and Clinics), Travis Smith(Gundersen Health System), Harish Lavu(Thomas Jefferson University), Brian C. Brajcich(American College of Surgeons), Scott Celinski(Baylor University Medical Center), Stephen W. Behrman(Baptist Memorial Health Care), Michael G. House(Indiana University – Purdue University Indianapolis), Ryan J. Ellis(Memorial Sloan Kettering Cancer Center), Vanessa Thompson(American College of Surgeons), Paul J. Karanicolas(Sunnybrook Health Science Centre), Jason B. Liu(The University of Texas MD Anderson Cancer Center), Adam C. Yopp(Southwestern Medical Center), Mary Dillhoff(The Ohio State University), Sharon M. Weber(University of Wisconsin–Madison), Kimberly A. Bertens(University of Ottawa), Henry A. Pitt(Rutgers, The State University of New Jersey), Susan K. Seo(Memorial Sloan Kettering Cancer Center), David J. Bentrem(Northwestern University), Michele Babicky(Providence Portland Medical Center)
Cited by 121
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Prevention of VTE in Nonorthopedic Surgical Patients
|CHEST Journal|2012|2.1k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k